medline.ch Urologie-Nephrologie Tumoren BPH

	Erratum: Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer: Erratum. Curr Urol Wang Q, Xu W, Ying L, Shi H, Sun Y, Feng W, Xu H, Xie J, Wei H, Yang Z, Wang H. PMID: 40314013 [PubMed]
	Methyltransferase-like 3 is a target for the diagnose and therapy of clear cell renal carcinoma. Front Pharmacol Xiao D, Su X. PMID: 40313614 [PubMed]
	Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer. Curr Urol Wang Q, Xu W, Ying L, Shi H, Sun Y, Feng W, Xu H, Xie J, Wei H, Yang Z, Wang H. PMID: 40313422 [PubMed]
	Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review. Curr Urol Ding S, Wu C, Cao J, Lyu J. PMID: 40313419 [PubMed]
	Current role of radiomics and radiogenomics in predicting oncological outcomes in bladder cancer. Curr Urol O'Sullivan NJ, Temperley HC, Corr A, Meaney JFM, Lonergan PE, Kelly ME. PMID: 40313417 [PubMed]
	Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer. medRxiv Perimbeti S, Jamroze A, Gopalakrishnan D, Jain R, Jiang C, Holleran JL, Parise RA, Bies R, Quinn D, Attwood K, Liu X, Kirk JS, Beumer JH, Tang DG, Chatta G. PMID: 40313289 [PubMed]
	MRI-based habitat analysis of vascular and nerve invasion in the tumor microenvironment: an advanced approach for prostate cancer diagnosis. Front Oncol Guan B, Huang C, Wang Y, Zhang J, Li X, Hao Z. PMID: 40313255 [PubMed]
	Extra-Adrenal Paraganglioma Mimicking a Hilar Lymph Node Metastasis From Testicular Cancer: A Case Study. Thorac Cancer Nakatsuka M, Takamori S, Kabasawa T, Shimada S, Endo M, Shiono S. PMID: 40313049 [PubMed - indexed for MEDLINE]
	Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study. Int J Urol Yoneyama F, Shinohara M, Kawashima Y, Yoneyama A, Ishii N, Oishi T, Tanaka R, Miura H, Kodama H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Sato S, Ohyama C, Hatakeyama S. PMID: 40312917 [PubMed - as supplied by publisher]
	Relationship between use of desmopressin in male patients with lower urinary tract symptoms and occurrence of hyponatremia: A nationwide population-based study using the National Health Insurance Service database. Investig Clin Urol Jeon BJ, Tae BS, Park JY, Bae JH. PMID: 40312904 [PubMed - indexed for MEDLINE]
	Arthritis increases the risk of prostate cancer: Results from the National Health and Nutrition Examination Survey 2005-2018 and two-sample Mendelian randomization analysis. Investig Clin Urol Yuan X, Shi R, Jing Q, Cao X, Zhang X. PMID: 40312901 [PubMed - in process]
	Evaluating prostate cancer diagnostic methods: The role and relevance of digital rectal examination in modern era. Investig Clin Urol Chung Y, Hong SK. PMID: 40312897 [PubMed - indexed for MEDLINE]
	É‘1,3-mannosyltransferase promotes the malignant progression of bladder cancer through activating TNF signaling pathway. Eur J Med Res Liu M, Zhang J, Zhu S, Jiang W, Yan Y, Zheng Q, Li S. PMID: 40312703 [PubMed - indexed for MEDLINE]
	Artificial Intelligence in Prostate Cancer Diagnosis on Magnetic Resonance Imaging: Time for a New PARADIGM. Eur Urol Ng AB, Giganti F, Kasivisvanathan V. PMID: 40312251 [PubMed - as supplied by publisher]
	PSMA-Targeted Biopsy With Fusion Guidance for Detecting Clinically Significant Prostate Cancer in Men With Negative MRI-Feasibility and Diagnostic Performance of a Pilot Single-Center Prospective Study. Clin Genitourin Cancer Bianchi L, Cangemi D, Farolfi A, Sgro CMP, Giorgio AD, Castellucci P, Gaudiano C, Corcioni B, Giunchi F, Degiovanni A, Pirelli V, Mignogna C, Rotaru V, Mottaran A, Piazza P, Droghetti M, Ragni M, Romei F, Mosconi C, Fiorentino M, Schiavina R, Fanti S, Brunocilla E. PMID: 40312220 [PubMed - as supplied by publisher]
	Association of Deep and Durable Prostate-specific Antigen Responses with Outcomes in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials. Eur Urol Oncol Wallis CJD, Ekberg S, Morgans AK, Boegemann M, Paracha N, Gallagher E, Crowther MJ, Shore N. PMID: 40312181 [PubMed - as supplied by publisher]
	Adjuvant Docetaxel Versus Surveillance in Intermediate- or High-risk Prostate Cancer After Radical Curative Radiotherapy: Final Survival Results from the SPCG-13 Trial. Eur Urol Oncol Kellokumpu-Lehtinen PL, Fransson AS, Marttila T, Lehtinen I, Huttunen T, Thellenberg-Karlsson C, SPCG-13 Investigators. PMID: 40312180 [PubMed - as supplied by publisher]
	Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles. Eur Urol Oncol Frantzi M, Tymoszuk P, Salcher S, Gomez-Gomez E, Morillo AC, Melchior F, Blanca A, Mischak H, Vlahou A, Pircher A, Heidegger I. PMID: 40312179 [PubMed - as supplied by publisher]
	Editorial Comment on Low baseline IsoPSA Index is associated with a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men with an Elevated PSA. Urology Assani KD, Scarpato KR. PMID: 40311764 [PubMed - as supplied by publisher]
	The complement system and kidney cancer: pathogenesis to clinical applications. J Clin Invest Aalinkeel R, Quigg RJ, Alexander J. PMID: 40309765 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 176048

Seite 1 von 8803



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung